Arrangement of an Implant and/or a Unit Belonging to Said Implant, and Method for Production of the Implant and/or Unit

ABSTRACT

An implant ( 5, 13 ) and/or a unit ( 9 ), e.g. spacer sleeve, belonging to said implant is/are intended to extend through a hole ( 4 ′) formed in a jaw bone ( 2 ) and through soft tissue ( 3 ) belonging to the jaw bone and to comprise one or more outer layers of principally titanium dioxide. Each layer consists of crystalline titanium dioxide which largely or completely assumes the anatase phase. The invention also relates to a method for production of such a dental implant ( 5, 13 ) and/or of a unit ( 9 ) belonging to it, which has one or more outer layers of titanium dioxide. The method is an anodic oxidation method in which the part or parts bearing the outer layer(s) is/are applied to electrolyte under voltage, e.g. comprising sulfuric acid and phosphoric acid, and the voltage (U) and the dwell time of the part or parts in the electrolyte are chosen such that titanium dioxide, largely or completely assuming the crystalline anatase phase, is formed. Excellent bone guidance and soft tissue integration can be achieved in this way.

Arrangement with an implant and/or a unit belonging to said implant, andmethod for production of the implant and/or unit

The present invention relates to an arrangement with an implant and/or aunit, e.g. spacer sleeve, belonging to said implant, which are intendedto extend through a hole formed in a jaw bone and through soft tissue ofthe jaw bone and to comprise one or more outer layers of titaniumdioxide. The invention also relates to a method for production of theimplant and/or unit.

Implants and spacer sleeves, or units passing through soft tissue, andmethods for production of implants and such units in the dental fieldare already well known on the market and from descriptions in the patentliterature and the general literature. Most of the known implants andunits are designed in line with a general attempt to achieve goodimplantation results at reasonable costs. There is therefore a generalneed to obtain, between the implant and the jaw bone and between thepart of the implant and/or unit extending through the soft tissue andthe soft tissue, a good and also esthetically satisfactory integrationwhich does not tend to degenerate after a period of implantation. Thesame Applicant as the one filing the present patent application has alsosubmitted, inter alia, Swedish patent application 0301149-1, in whichexcellent integration was made possible between jaw bone and implant.Reference is also made to the patent applications filed at the same timeas the present one, namely SE 03322-0 and SE 03324-8.

There is, however, a need for even better implants and units and formethods for production of implants and units. Thus, for example, it isimportant that bone growth can be improved and accelerated in connectionwith implants. There is an evident need for short fitting times, and itis more difficult for patients and dental personnel to accept long andprotracted treatment periods. It is also important to achieve a goodesthetic result in the long term, and also good integration of the upperparts of the implant or unit with respect to the jaw bone and softtissue.

The object of the present invention is to solve these problems, interalia, and it makes use of the knowledge that titanium dioxide can bearranged on the outer surface or outer surfaces of the implant. In apreferred embodiment, the application will be effected by means ofso-called anodic oxidation, based on known methods according to Swedishpatents 99019474-7 and 0001202-1. However, this known oxidation methodhas not been proposed to function in the crystalline range. Reference isalso made to JP 2000116673 ad JP 11033106, Kokubo et al., relating toimplant material which can be used in the crystalline range, but inprinciple outside the dental field.

The feature which can be regarded as characterizing an arrangementaccording to the invention is that each of the layers mentioned in theintroduction will consist of crystalline titanium dioxide which largelyor completely assumes the anatase phase.

In further developments of the inventive concept, the anatase phase ispresent in a proportion of 70-100% in one or more layers. The layers canalso have a mean thickness in the thickness range of 0.05-10 μm,preferably 0.5-10 μm. In one embodiment, a large part or all of theouter surface or outer surfaces of the implant or of the unit isprovided with the crystalline titanium oxide largely or completelyassuming the anatase phase. In this way, the titanium dioxide layeraccording to the invention will stimulate excellent bone guidance andsoft tissue integration. The crystalline titanium dioxide can besupplemented with another type of substance stimulating bone growth,e.g. BMP (bone morphogenetic protein). Further embodiments of the novelimplant are set out in the attached dependent claims concerning theimplant.

The feature which can principally be regarded as characterizing thenovel method is that it comprises an anodic oxidation procedure. In thismethod, the part or parts bearing said outer layer or outer layers areapplied to a liquid or electrolyte under voltage, e.g. sulphuric acidand phosphoric acid. The electrolyte composition and the voltage and thedwell time of the actual part or parts of the implant in the liquid arechosen so that titanium dioxide, largely or completely assuming theanatase phase, is formed. Different electrolyte compositions areassociated with different voltages.

In one embodiment, the voltage is chosen with values between 100 and 270volts. At lower voltages, the titanium dioxide layer becomes amorphous,and at higher voltages the quantity of rutile in the titanium dioxidelayer increases.

By means of what has been proposed above, an excellent and effectivebone growth function is obtained which is advantageous both from thepoint of view of strong growth of bone and from the point of view oftime (rapid growth). The layer or layers also provide the possibility ofeffective soft tissue integration at the part or portion that can beplaced against or extend through the soft tissue. The implant productionis highly advantageous because methods and procedures already known perse can be used. No modifications are needed to the actual implant orunit structure, and they can be distributed and handled in the manneralready practised in the dental field. Likewise, the actual implantationwork can follow already established routines, with the difference thatbone growth, soft tissue integration and speed are increased. Layerswith different properties can be positioned in all areas or selectedareas of the implant, should this be desired.

Presently proposed embodiments of an arrangement and of a method forproduction of the latter will be described below with reference to theattached drawings, in which:

FIG. 1 shows a diagrammatic vertical view of an implant provided with atitanium dioxide layer in anatase phase and fitted in a jaw bone (ofwhich part is shown), which layer, compared to the prior art, has anincreased ability to guide bone formation,

FIG. 2 shows a vertical view of an implantation case different than theone according to FIG. 1,

FIG. 3 shows a vertical view of parts of an implant in a jaw bone (ofwhich part is shown) and a through-piece belonging to the implant andextending through soft tissue, and portions of the unit that can beplaced against the soft tissue have titanium dioxide layers in anatasephase,

FIG. 4 shows a diagrammatic side view of titanium dioxide in the anatasephase being applied to an implant by means of anodic oxidation,

FIG. 5 shows a diagrammatic side view of titanium dioxide in the anatasephase being applied to a unit or soft tissue through-piece belonging tothe implant, and

FIG. 6 shows, in graph form, the layer thickness as a function of theapplied voltage value.

According to FIG. 1, a bone 1 comprises jaw bone 2. On top of the jawbone there is an area of soft tissue 3. The jaw bone is initiallyprovided with a hole, shown symbolically by reference number 4. Animplant 5 which can be of a type known per se is arranged in the hole.The implant can thus comprise, for example, an outer thread 5 a by meansof which said implant can be screwed into the hole 4. The hole can bethreaded or unthreaded. The implant is also provided with an upperflange-like portion 5 b which has a peripheral surface 5 b′ that can beplaced against the jaw bone in the upper areas 2 a thereof. The implantcan also comprise or be connected to a unit or soft tissue through-piece5 c, which can consist of or function as a spacer sleeve. On the softtissue through-piece 5, the implant is intended to support a prosthesis,which is indicated symbolically by reference number 6. The surface ofthe jaw bone facing the portion 5 b is indicated by 2 a′.

The implant according to FIG. 1 is provided along all or most of itsouter surface with a thin layer of titanium dioxide which completely orpartially, preferably substantially, assumes the crystalline formanatase. Said anatase has been shown to have a powerfulbone-growth-stimulating effect, which in FIG. 1 has been illustrated bybone growth 7 surrounding the implant along most of its length. Theanatase layer has thus made the surface of the implant able to guidebone formation. The structure of the layer is described in more detailbelow. In the case according to FIG. 1, the titanium dioxide layer hasnot been applied to the upper parts of the implant, meaning that a smallspace with soft tissue is present between the portion and the jaw boneas a result of slight bone absorption. Said space 8, which is normallynot desirable, has been shown for illustrative purposes.

The implant according to the illustrative embodiment in FIG. 2 can havethe same basic structure as the implant 5′ in FIG. 1. In this case, theimplant has titanium dioxide in the anatase phase only at its upperparts 5 b′ and 5 c. The application of titanium dioxide in the anatasephase has brought about considerable bone growth 7′ in the areaconcerned, cf. space 8 in FIG. 1. The titanium dioxide in the anatasephase can thus be used to effectively avoid bone absorption in the areaaccording to the space 8 and in this way to avoid bone absorption andsubsidence of soft tissue according to FIG. 1. This guarantees a goodesthetic result even in the long term. Of course, the implant 5′according to FIG. 2 can be provided with titanium dioxide along the fullouter extent of the implant. In this case, the hole formation has alsobeen shown more clearly and is indicated by 4′. The arrangements shownin FIGS. 1 and 2 thus use the ability of the anatase layer to guide boneformation, which ability can be extended substantially compared to knowndental techniques.

FIG. 3 shows a unit or through-piece 9 extending through the soft tissue3. The unit 9 has a length L in the height direction. Along a length 1,which can be ⅔ of L, the unit has been provided, on its outer surfacepart 9 a, with a thin anatase layer 10, i.e. with a titanium dioxidelayer in the anatase phase. On the remaining part 9 b, with length 1′,of the outer surface, the unit has a thin titanium dioxide layer whichcan be amorphous, rutile or in the anatase phase. Said remaining outersurface part is directed towards the oral cavity, indicated symbolicallyby 10. In FIG. 3, reference number 11 also symbolically represents oralepithelium which has a limited extent along the surface of thespacer/unit/through-piece. The connective tissue area 12 extends acrossthe greater part of the area or outer surface 9 a, 9 b and thuscorresponds to the outer surface 9 a along the extent 1. Thethrough-piece 9 can be integrated with or applied in a known manner tothe jaw bone implant 13 which in FIG. 3 is fitted in a hole formed injaw bone 2 in the same way as in the illustrative embodiment accordingto FIGS. 1 and 2. The through-piece is also arranged here to support aprosthetic superstructure 14.

FIGS. 4 and 5 show the principle of anodic oxidation, in which use ismade of a vessel 15 with liquid containing an electrolyte, e.g. sulfuricacid and phosphoric acid in accordance with the technique indicated insaid patent publications. In an anode and cathode arrangement, theimplant represents an anode 16, and a contact unit a cathode 17. Theimplant is designated by reference number 18 and is completely orpartially immersed in the electrolyte 19. The anode and the cathode areconnected respectively to the plus pole and minus pole of a voltagesource which is symbolized by 20. The voltage source can comprisecontrol members of a known type to ensure that the voltage between theanode/implant and the cathode/contact unit located in the electrolytecan be varied if necessary. Thus, the voltage U can, for a certaincomposition of the electrolyte, be varied or set to a first value in therange of 100-270 volts. If the electrolyte has another composition, thevalue is set to another value which can be in the stated range, i.e.between 100 and 270 volts, so as to obtain on the outer surface or outersurfaces in question a titanium dioxide layer according to the above,which assumes the crystalline anatase phase 7″. The implant 18 can beacted on in the direction of the arrows 20, and it will be appreciatedthat the titanium dioxide layer can be varied in terms of thickness andphase by controlling the voltage value by means of said control membersor setting members and by moving the implant in the directions of thearrows 20. The immersion time of the surface or surface parts is alsocrucial in determining the structure of the titanium dioxide layer.

FIG. 5 shows the case where a soft tissue through-piece or unit 1 iscoated completely or partially with titanium dioxide in the anatasephase, using equipment according to FIG. 4. In the present example,lower parts (cf. 9 a in FIG. 3) are immersed in the liquid bath orelectrolyte 19. Otherwise, the arrangements according to FIGS. 4 and 5function in a corresponding manner.

FIG. 6 shows how the thickness T can vary as a function of the voltage Ufor a certain immersion time and for a given electrolyte. The dependenceof the layer thickness on, inter alia, the voltage has been representedby the curve 17. The graph also indicates a first voltage point U1 wherethe anatase phase occurs for the layer (cf. 7), while U2 indicates thevoltage where the rutile phase occurs.

The thickness of the titanium dioxide layer can be chosen in the rangeof 0.05-10 μm, for example 0.5-10 μm. Anatase is present in a proportionof 70-100% in the layer in question. The implant and/or the soft tissuethrough-piece thus has a portion or portions that can be placed againstthe jaw bone and/or soft tissue. Each such portion can be unthreaded orcan be provided with a thread, groove or pattern. Different layers canbe provided on locally distinct sites or on top of one another.

To supplement the ability of the anatase to guide bone fomation and toaid soft tissue integration, the titanium dioxide layer in anatase canbe provided with growth-stimulating substance(s), e.g. BMP, which havebone-inducing properties.

The invention is not limited to the embodiment shown above by way ofexample, and instead it can be modified within the scope of the attachedpatent claims.

1. A dental component for extending at least partially a hole formed injaw bone and through soft tissue belonging to the jaw bone, the dentalcomponent comprising one or more outer layers comprising titaniumdioxide, wherein each layer comprises of crystalline titanium dioxidewhich largely assumes the anatase phase.
 2. The dental component as inclaim 1, wherein anatase is present in a proportion of 70%-100% in eachlayer (7).
 3. The dental component as in claim 1, wherein each layer hasa thickness about 0.05-10 μm.
 4. The dental component as in claim 1,wherein a majority of the outer surfaces of the dental component areprovided with the crystalline titanium dioxide largely assuming theanatase phase.
 5. The dental component as in claim 1, wherein one ormore outer surfaces of the dental component are provided with thecrystalline titanium dioxide largely assuming the anatase phase.
 6. Thedental component as in claim 1, wherein the dental component comprises aportion which can be placed against the soft tissue.
 7. The dentalcomponent as in claim 1, wherein each titanium dioxide layer in thecrystalline anatase phase comprises a bone stimulation substance.
 8. Thedental component as in claim 1, wherein an outer thread located on thedental component is provided with outer layers of crystalline titaniumdioxide largely assuming the anatase phase.
 9. The dental component asin claim 1, wherein a portion of the dental component configured to beplaced against the soft tissue comprises a threadless outer surface. 10.The dental component as in claim 1, wherein a portion configured toextend through the soft tissue is coated with layers of crystallinetitanium dioxide in the anatase. phase along, and the remaining lengthor surface of said portion comprises constituting a part directed awayfrom the implant can be substantially amorphous, rutile, or in theanatase phase, and the length section with anatase can interact with thesoft tissue in the connective tissue area.
 11. A method for producing adental component, comprising: applying to outer layers of the dentalcomponent a liquid or electrolyte under voltage, and choosing thevoltage and the dwell time of the dental component in the liquid orelectrolyte such that titanium dioxide, largely assumes the crystallineanatase phase.
 12. The method as in claim 11, wherien characterized inthat, for a given or predetermined first concentration of electrolyte,the voltage is chosen with a first value in the range of 100-270 volts,and in that, at a second concentration or composition of electrolyte,the voltage is chosen with a second value.
 13. The method as claimed inpatent claim 11 or 12, characterized in that the crystalline titaniumdioxide is supplemented with a growth-stimulating substance, e.g. BMP,and/or measures.
 14. The dental component of claim 1, wherein each layercomprises of crystalline titanium dioxide which completely assumes theanatase phase.
 15. The dental component as in claim 3, wherein eachlayer has a thickness of between about 0.5-10 μm.
 16. The dentalcomponent as in claim 1, wherein_the bone stimulationsubstance-comprises BMP.
 17. The method as in claim 11, wherein theliquid comprises comprising sulfuric acid or phosphoric acid.